Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Si-Bone (SIBN) EBIT (2017 - 2026)

Si-Bone has reported EBIT over the past 10 years, most recently at -$5.1 million for Q1 2026.

  • For Q1 2026, EBIT rose 31.91% year-over-year to -$5.1 million; the TTM value through Mar 2026 reached -$19.9 million, up 35.01%, while the annual FY2025 figure was -$22.3 million, 36.65% up from the prior year.
  • EBIT for Q1 2026 was -$5.1 million at Si-Bone, down from -$2.5 million in the prior quarter.
  • Over five years, EBIT peaked at -$2.5 million in Q4 2025 and troughed at -$17.9 million in Q2 2022.
  • A 5-year average of -$10.0 million and a median of -$11.2 million in 2023 define the central range for EBIT.
  • Biggest five-year swings in EBIT: tumbled 45.73% in 2022 and later skyrocketed 56.07% in 2024.
  • Year by year, EBIT stood at -$11.3 million in 2022, then fell by 10.73% to -$12.5 million in 2023, then skyrocketed by 56.07% to -$5.5 million in 2024, then surged by 55.17% to -$2.5 million in 2025, then crashed by 106.78% to -$5.1 million in 2026.
  • Business Quant data shows EBIT for SIBN at -$5.1 million in Q1 2026, -$2.5 million in Q4 2025, and -$5.4 million in Q3 2025.